[{"address1": "St. Luke Tower", "address2": "13th Floor 8-1 Akashi-cho Chuo-ku", "city": "Tokyo", "zip": "104-0044", "country": "Japan", "phone": "81 3 6264 3481", "website": "https://www.sanbio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson's disease, spinal cord injury, and Alzheimer's disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.", "fullTimeEmployees": 29, "companyOfficers": [{"maxAge": 1, "name": "Mr. Toru  Kawanishi", "age": 56, "title": "Co-Founder & Executive Chairman", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Keita  Mori MBA", "age": 56, "title": "Co-Founder, President, Executive Officer, CEO & Representative Director", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yoshihiro  Kakutani", "title": "Corporate Officer of Management Administration", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Gillas", "title": "Senior Vice President of Human Resources & Corporate Services", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Naoki  Tsukahara", "title": "Senior Corporate Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kazumi  Sawaguchi Ph.D.", "title": "Corporate Officer and Head of Japan Regulatory Affairs & Quality Compliance Japan", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Keizo  Nakada", "title": "Corporate Officer & Head of Production", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Shinya  Hirata", "title": "Corporate Officer & Head of Research and Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dai  Chida", "title": "Senior Scientific Advisor", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Masumi  Akahori", "title": "In charge of IR", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 3.85, "open": 3.85, "dayLow": 3.85, "dayHigh": 3.85, "regularMarketPreviousClose": 3.85, "regularMarketOpen": 3.85, "regularMarketDayLow": 3.85, "regularMarketDayHigh": 3.85, "beta": 0.342, "volume": 1000, "regularMarketVolume": 1000, "marketCap": 301366048, "fiftyTwoWeekLow": 3.8, "fiftyTwoWeekHigh": 4.25, "fiftyDayAverage": 3.85, "twoHundredDayAverage": 3.86825, "currency": "USD", "enterpriseValue": -3095499776, "floatShares": 46139233, "sharesOutstanding": 68629696, "heldPercentInsiders": 0.28845, "heldPercentInstitutions": 0.040799998, "bookValue": 34.956, "priceToBook": 0.11013845, "lastFiscalYearEnd": 1706659200, "nextFiscalYearEnd": 1738281600, "mostRecentQuarter": 1714435200, "netIncomeToCommon": -2161999872, "trailingEps": -0.21, "enterpriseToEbitda": 0.829, "exchange": "OEM", "quoteType": "EQUITY", "symbol": "SNBIF", "underlyingSymbol": "SNBIF", "shortName": "SANBIO COMPANY LIMITED", "longName": "SanBio Company Limited", "firstTradeDateEpochUtc": 1444656600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "19f850f4-963e-3216-93b1-7a9da884775c", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.85, "recommendationKey": "none", "totalCash": 3956999936, "totalCashPerShare": 57.816, "ebitda": -3732499968, "totalDebt": 598000000, "quickRatio": 7.867, "currentRatio": 8.543, "debtToEquity": 24.927, "returnOnAssets": -0.45209, "returnOnEquity": -0.69306, "financialCurrency": "JPY", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]